Incorrect storage of drug; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number TD2FD, expiry date MAY-2026) for prophylaxis. Co-suspect products included HBV (Engerix B) (batch number 95D74, expiry date MAR-2025) for prophylaxis and HAV (Havrix) (batch number BM4R5, expiry date APR-2026) for prophylaxis. Additional patient notes included patient weight: 119. On 05-AUG-2024, the patient received the 1st dose of Boostrix (intramuscular, left deltoid), the 1st dose of Engerix B (intramuscular, right deltoid) and the 2nd dose of Havrix (intramuscular, right deltoid). On an unknown date, an unknown time after receiving Boostrix, Engerix B and Havrix, the patient experienced incorrect storage of drug (Verbatim: Incorrect storage of drug). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 02-DEC-2024 The patient received Boostrix, Engerix -B and Havrix vaccine. The other health professional reported that she does not know which vaccines were administered after the temperature excursion to which patients which led to incorrect storage of drug. This was 1 of 15 cases reported by same reporter.